公开(公告)号：US09993549B2

公开(公告)日：2018-06-12

申请号：US15032718

申请日：2014-10-30

Applicant: HISAMITSU PHARMACEUTICAL CO., INC.

Inventor： Seiji Tokumoto ,  Kazuya Machida ,  Nao Kurokawa ,  Rie Namiki

IPC: A61K39/39 ,  A61K9/08 ,  A61K9/00 ,  A61K47/10 ,  A61K9/70 ,  A61K39/00

CPC classification number: A61K39/39 ,  A61K9/0014 ,  A61K9/0021 ,  A61K9/08 ,  A61K9/7023 ,  A61K39/0008 ,  A61K47/10 ,  A61K2039/54 ,  A61K2039/55511

Abstract: An adjuvant composition of the present invention contains lauryl alcohol and propylene glycol. Contents of the lauryl alcohol and the propylene glycol are 0.5 to 25% by mass and 8.0 to 99.5% by mass, relative to the total mass of the adjuvant composition, respectively. The lauryl alcohol is dissolved, and the adjuvant composition is used for transdermal or transmucosal administration.